Access to Medicine Foundation

NOW ONLINE: The 2024 Access to Medicine Index #ATMI24 provides an in-depth analysis of what the #pharma industry is doing to bridge the gap in #EquitableAccess. Despite incredible progress in #GlobalHealth, half of the global population still struggles to access the medicines and #healthcare they desperately need. The 2024 Access to Medicine Index shows an overall stagnation in pharmaceutical companies’ efforts to improve access to essential healthcare products across low- and middle-income countries #LMICs. While some modest progress has been made, the potential for improving access is still far from realised and the pace of change is slow. Watch Jayasree Iyer, the Foundation's CEO, as she shares the key findings from this ninth iteration of the Index and discusses how the industry has performed over the past two years. Read the 2024 Access to Medicine Index here ➡ https://lnkd.in/e5g_YHCm #AccesstoMedicine #AccesstoHealthcare #HealthEquity Foreign, Commonwealth and Development Office, Ministerie van Buitenlandse Zaken, Bill & Melinda Gates Foundation, The Helmsley Charitable Trust, Wellcome Trust, Stewart Investors, AXA Investment Managers, Mira M. Fricke, John Muchangi, Holger Alich, Lena Hunter, Sohini Das

As we close the year, we reflect on the challenges and opportunities for improving access to healthcare globally. 2024 marked the release of the 9th Access to Medicine Index, a critical benchmark that holds pharmaceutical companies accountable for their contributions to global health. While the Index highlights some progress, it also underscores the urgent need for companies to expand their efforts in ensuring that essential medicines and healthcare products reach those who need them most. In her take on the 2024 Index, our CEO, Jayasree Iyer, outlines the steps that pharmaceutical companies and their partners can take to transform lives. From expanding reach in underserved communities to scaling up voluntary licensing and technology transfers, the path forward is clear and the time to act is now. As we prepare for 2025, we remain committed to driving change and amplifying solutions that bring affordable, lifesaving medicines to low- and middle-income countries. Join us in this mission. Read Jayasree’s reflections on the 2024 Index ➡️ https://lnkd.in/eCVVgmeN Thank you to everyone who has supported our work this year. Here's to making an even greater impact in the year ahead. 🔗 https://lnkd.in/eTjKCG-T #AccesstoMedicine #ATMI24 #HealthEquity #AccesstoHealthcare #EquitableAccess #GlobalHealth #healthcare #pharma

Join us for a webinar, co-hosted by the Access to Medicine Foundation and The International Centre for Antimicrobial Resistance Solutions (ICARS), to explore how we can strengthen antimicrobial stewardship in low-and middle-income countries #LMICs Discover expert insights, actionable solutions, and strategies to tackle the growing #AMR crisis through sustainable, locally tailored approaches. 📅 January 21, 2025 🕚 11:00 - 12:30 CET Register ➡️ https://bit.ly/3BpzZ9e

Nikkei covers the release of the 2024 #AccesstoMedicine Index #ATMI24, highlighting in particular the performance of Japanese companies analysed in the report. The article quotes the Foundation's Director of Operations, Marijn Verhoef: "We would like Japanese #pharma companies to consider expanding the areas they cover by setting up bases and collaborating with partners to give options to people in low- and middle-income countries #LMICs." Read the article ➡️ https://lnkd.in/dEqk-C64 #HealthEquity #EquitableAccess #AccesstoHealthcare #GlobalHealth

STAT's ed silverman spoke to the Foundation's CEO, Jayasree Iyer, about the findings and opportunities highlighted in the 2024 #AccesstoMedicine Index #ATMI24. The analysis reveals that while some #pharma companies are adapting their business models to address underserved populations, industry efforts still fall significantly short. Sharing her insights on industry progress, Iyer notes: "Since we began measuring these companies, we expected the pace of progress would pick up, but it’s falling short — and not a little bit short, but a lot short." Read the full article ➡️ https://lnkd.in/emhtUyH6 #HealthEquity #EquitableAccess #AccesstoHealthcare #GlobalHealth

For POLITICO Europe, Giedrė Peseckytė and the Foundation's CEO, Jayasree Iyer, delve into the findings of the 2024 #AccesstoMedicine Index #ATMI24. The article highlights the worryingly low representation of resource-poor populations in #ClinicalTrials and fewer technology transfers in 2024 than in 2022 to partners in lower-income countries. Reflecting on the overall industry progress in the past two years, Iyer notes: "The pace at which we expect the progress to be at is not where it needs to be." Read the full article ➡️ https://lnkd.in/eCcXzx8i #HealthEquity #EquitableAccess #AccesstoHealthcare #GlobalHealth

Today, we co-hosted the investor launch event for the 2024 Access to Medicine Index #ATMI24 with AllianceBernstein in New York. This marks the second investor-focused event for the 2024 Index, following one held earlier this year in London. The discussions highlighted the essential role of public-private partnerships in advancing #AccesstoMedicine, particularly in low- and middle-income countries #LMICs. The global #HIV response was spotlighted as a powerful example of how such partnerships can deliver impactful solutions. #Investors at the event emphasised the value of the Access to Medicine Index as a critical #ESG tool, noting how it informs investment decisions, identifies leaders in access strategies and promotes accountability across the #pharma industry. Read the 2024 Access to Medicine Index ➡️ https://lnkd.in/e5g_YHCm #investing #ResponsibleInvestment #SustainableInvestment #ImpactInvesting #HealthEquity #EquitableAccess #AccesstoHealthcare Pauline L'Hénaff Twinelle B. Camille Romero Claudia Martínez

In the latest episode of the Pensions for Purpose podcast, Clare Wood from Stewart Investors shares insights on how the Foundation's work is helping #investors identify #pharma companies that are well governed and take their social purpose seriously. Listen to the full discussion to learn more about how investors can support #healthcare access and SDG 3, contributing to a healthier future for all. ⤵️ #investing #ResponsibleInvestment #SustainableInvestment #ImpactInvesting #ESG #AccesstoMedicine #EquitableAccess #HealthEquity

Are you passionate about advancing global #HealthEquity? Join our team in Amsterdam! We’re looking for a Company Engagement Officer to manage relationships with #healthcare companies, with a particular focus on the #MedicalOxygen sector. In this role, you will contribute to initiatives that drive access to essential healthcare products in low- and middle-income countries #LMICs. The ideal candidate brings experience in the healthcare industry, strong diplomacy and relationship-building skills and a drive to create meaningful change in #GlobalHealth. Does this sound like you? Learn more and apply ➡️ https://lnkd.in/esXvuirM #hiring #vacancy #HiringNow #NGOJobs #AmsterdamJobs #OfficeJobs #AccesstoMedicine #EquitableAccess #AccesstoHealthcare

For The Hindu businessline, Jyothi Datta covers the launch of the 2024 #AccesstoMedicine Index #ATMI24, which analyses 20 of the world’s largest #pharma companies on their efforts to improve access to essential medicines in low- and middle-income countries #LMICs. The article highlights the slowdown in licensing activities, with only two new licences issued during the period of analysis for the 2024 Index compared to six licences identified in the 2022 Index. Datta notes that the slowdown could impact Indian drugmakers, who participate in the global #VoluntaryLicensing agreements and technology transfer pacts. Read the full article ➡️ https://lnkd.in/eKzZEEdu #HealthEquity #EquitableAccess #AccesstoHealthcare #GlobalHealth #VL #NEVL #TechTransfer